Efficacy dosage titration of lufenuron against developmental stages of fleas (Ctenocephalides felis felis) in cats

Thirty-two mixed-breed male and female cats were blocked by sex, arranged by body weight from greatest to least, and allocated to 4 groups of 8 (4 male, 4 female) cats, using random numbers. Cats in each of 3 groups were treated orally with a 7% suspension formulation of lufenuron at dosage of 15, 3...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of veterinary research Vol. 55; no. 1; p. 98
Main Authors:	Blagburn, B L, Vaughan, J L, Lindsay, D S, Tebbitt, G L
Format:	Journal Article
Language:	English
Published:	United States 01-01-1994
Subjects:	Administration, Oral Animals Benzamides - administration & dosage Benzamides - therapeutic use Cat Diseases Cats Female Insecticides - therapeutic use Male Oviposition - drug effects Parasitic Diseases - prevention & control Parasitic Diseases, Animal Siphonaptera - growth & development
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Thirty-two mixed-breed male and female cats were blocked by sex, arranged by body weight from greatest to least, and allocated to 4 groups of 8 (4 male, 4 female) cats, using random numbers. Cats in each of 3 groups were treated orally with a 7% suspension formulation of lufenuron at dosage of 15, 30, or 45 mg/kg of body weight. Cats in the fourth group were treated orally with an excipient suspension without lufenuron. Cats were infested with newly emerged, unfed cat fleas (Ctenocephalides felis felis) on days -7 and -3 before treatment and at approximately weekly intervals after treatment. Flea eggs were collected from beneath each cat on selected days before and after treatment and placed in an artificial rearing medium. Flea eggs and medium were kept for 35 days in an insectary to determine effects of lufenuron or excipient suspension on emergence of adults of the F1 generation. Lufenuron was 100% effective in inhibiting development of C felis at all dosages for 11 days after treatment. Thereafter, efficacy exceeded 92% in all dosages groups. On day 32, when the study was terminated, efficacy for each of the dosage groups was: 15 mg/kg, 95.2%; 30 mg/kg, 98.2%; and 45 mg/kg, 99.6%. Adverse reactions or side effects were not observed in cats, regardless of treatment dosage.
ISSN:	0002-9645
DOI:	10.2460/ajvr.1994.55.01.98